Cas no 356093-33-9 (N-(3-Methoxybenzyl)-2-phenylethanamine Hydrochloride)
N-(3-Methoxybenzyl)-2-phenylethanamine Hydrochloride Chemical and Physical Properties
Names and Identifiers
-
- N-(3-Methoxybenzyl)-2-phenylethanamine
- (3-methoxybenzyl)(2-phenylethyl)amine(SALTDATA: HCl)
- (3-Methoxy-benzyl)-phenethyl-amine
- N-[(3-methoxyphenyl)methyl]-2-phenylethanamine
- 356093-33-9
- AB00089870-03
- AKOS000235096
- STK130910
- AB00089870-01
- CS-0367764
- DTXSID50364604
- N-(3-methoxybenzyl)-2-phenylethan-1-amine
- NCGC00322604-01
- [(3-methoxyphenyl)methyl](2-phenylethyl)amine
- (3-methoxybenzyl)(2-phenylethyl)amine
- DB-086927
- N-(3-Methoxybenzyl)-2-phenylethanamine Hydrochloride
-
- MDL： MFCD01469597
- Inchi： 1S/C16H19NO/c1-18-16-9-5-8-15(12-16)13-17-11-10-14-6-3-2-4-7-14/h2-9,12,17H,10-11,13H2,1H3
- InChI Key： TYYKFCZFMJZMIA-UHFFFAOYSA-N
- SMILES： O(C)C1=CC=CC(=C1)CNCCC1C=CC=CC=1
Computed Properties
- Exact Mass: 241.14700
- Monoisotopic Mass: 241.146664230g/mol
- Isotope Atom Count: 0
- Hydrogen Bond Donor Count: 1
- Hydrogen Bond Acceptor Count: 2
- Heavy Atom Count: 18
- Rotatable Bond Count: 6
- Complexity: 213
- Covalently-Bonded Unit Count: 1
- Defined Atom Stereocenter Count: 0
- Undefined Atom Stereocenter Count : 0
- Defined Bond Stereocenter Count: 0
- Undefined Bond Stereocenter Count: 0
- XLogP3: 3.2
- Topological Polar Surface Area: 21.3?2
Experimental Properties
- PSA: 21.26000
- LogP: 3.41840
N-(3-Methoxybenzyl)-2-phenylethanamine Hydrochloride Security Information
-
Hazardous Material Identification：
- HazardClass：IRRITANT
N-(3-Methoxybenzyl)-2-phenylethanamine Hydrochloride Customs Data
- HS CODE：2922299090
- Customs Data：
China Customs Code:
2922299090Overview:
2922299090. Other amino groups(naphthol\phenol)And ether\Esters [including their salts, Except those containing more than one oxygen-containing group]. VAT:17.0%. Tax refund rate:13.0%. Regulatory conditions:nothing. MFN tariff:6.5%. general tariff:30.0%
Declaration elements:
Product Name, component content, use to, The color of ethanolamine and its salt should be reported, The package of ethanolamine and its salt shall be declared
Summary:
2922299090. other amino-naphthols and other amino-phenols, other than those containing more than one kind of oxygen function, their ethers and esters; salts thereof. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:30.0%
N-(3-Methoxybenzyl)-2-phenylethanamine Hydrochloride Pricemore >>
| Related Categories | No. | Product Name | Cas No. | Purity | Specification | Price | update time | Inquiry |
|---|---|---|---|---|---|---|---|---|
| Alichem | A019118528-5g |
N-(3-Methoxybenzyl)-2-phenylethanamine |
356093-33-9 | 95% | 5g |
501.84 USD | 2021-06-16 | |
| TRC | B426565-10mg |
N-(3-Methoxybenzyl)-2-phenylethanamine Hydrochloride |
356093-33-9 | 10mg |
$ 50.00 | 2022-06-07 | ||
| TRC | B426565-50mg |
N-(3-Methoxybenzyl)-2-phenylethanamine Hydrochloride |
356093-33-9 | 50mg |
$ 65.00 | 2022-06-07 | ||
| TRC | B426565-100mg |
N-(3-Methoxybenzyl)-2-phenylethanamine Hydrochloride |
356093-33-9 | 100mg |
$ 80.00 | 2022-06-07 | ||
| SHANG HAI HAO HONG Biomedical Technology Co., Ltd. | 1438434-5g |
N-(3-methoxybenzyl)-2-phenylethan-1-amine |
356093-33-9 | 98% | 5g |
￥5938.00 | 2024-05-17 | |
| Crysdot LLC | CD12079399-5g |
N-(3-Methoxybenzyl)-2-phenylethanamine |
356093-33-9 | 95+% | 5g |
$487 | 2024-07-24 |
N-(3-Methoxybenzyl)-2-phenylethanamine Hydrochloride Related Literature
-
Min Kim,Jae-Joon Lee,Tengling Ye,Panagiotis E. Keivanidis,Kilwon Cho J. Mater. Chem. C, 2020,8, 1686-1696
-
Chung-Sung Yang,Mong-Shian Shih,Fang-Yi Chang New J. Chem., 2006,30, 729-735
-
Qiyuan Wu,Shangmin Xiong,Peichuan Shen,Shen Zhao,Alexander Orlov Catal. Sci. Technol., 2015,5, 2059-2064
-
Yong Ping Huang,Tao Tao,Zheng Chen,Wei Han,Ying Wu,Chunjiang Kuang,Shaoxiong Zhou,Ying Chen J. Mater. Chem. A, 2014,2, 18831-18837
Additional information on N-(3-Methoxybenzyl)-2-phenylethanamine Hydrochloride
Recent Advances in the Study of N-(3-Methoxybenzyl)-2-phenylethanamine Hydrochloride (CAS: 356093-33-9)
N-(3-Methoxybenzyl)-2-phenylethanamine Hydrochloride (CAS: 356093-33-9) is a chemically synthesized compound that has garnered significant attention in the field of medicinal chemistry and pharmacology. This compound, characterized by its unique structural features, has been the subject of recent studies exploring its potential therapeutic applications, particularly in the central nervous system (CNS). The following research brief consolidates the latest findings related to this compound, highlighting its pharmacological properties, mechanisms of action, and potential clinical implications.
Recent studies have focused on the compound's interaction with neurotransmitter systems, particularly its affinity for serotonin and dopamine receptors. Preliminary in vitro and in vivo experiments suggest that N-(3-Methoxybenzyl)-2-phenylethanamine Hydrochloride exhibits modulatory effects on these receptors, which could have implications for treating mood disorders such as depression and anxiety. The compound's structural similarity to known psychoactive substances has also prompted investigations into its potential as a novel psychotherapeutic agent.
One of the key findings from recent research is the compound's selective binding profile. Unlike many traditional CNS-active compounds, N-(3-Methoxybenzyl)-2-phenylethanamine Hydrochloride demonstrates a high degree of specificity for certain receptor subtypes, which may reduce off-target effects and improve therapeutic efficacy. This selectivity has been elucidated through advanced molecular docking studies and receptor binding assays, providing a solid foundation for further drug development efforts.
In addition to its CNS applications, recent studies have explored the compound's potential in other therapeutic areas. For instance, some research has indicated that N-(3-Methoxybenzyl)-2-phenylethanamine Hydrochloride may possess anti-inflammatory properties, mediated through its interaction with specific signaling pathways. These findings open up new avenues for investigating its use in conditions characterized by chronic inflammation, such as autoimmune diseases.
Despite these promising results, challenges remain in the development of N-(3-Methoxybenzyl)-2-phenylethanamine Hydrochloride as a therapeutic agent. Issues such as bioavailability, metabolic stability, and potential toxicity need to be addressed through further preclinical studies. Recent advancements in drug formulation technologies, including nanoparticle-based delivery systems, may offer solutions to some of these challenges, as evidenced by ongoing research in this area.
In conclusion, N-(3-Methoxybenzyl)-2-phenylethanamine Hydrochloride (CAS: 356093-33-9) represents a promising candidate for further pharmacological investigation. Its unique receptor binding profile and potential multi-therapeutic applications make it a compound of significant interest in the field of medicinal chemistry. Future research should focus on optimizing its pharmacokinetic properties and validating its efficacy and safety in clinical settings.
356093-33-9 (N-(3-Methoxybenzyl)-2-phenylethanamine Hydrochloride) Related Products
- 764651-75-4(N-(3-methoxybenzyl)-1-propanamine Hydrochloride)
- 60509-46-8(N-(3-Methoxybenzyl)-1-butanamine Hydrochloride)
- 625437-49-2(N-(2-methoxyphenyl)methylcyclopropanamine)
- 4579-60-6(N-(p-Hydroxyphenethyl)-N-(3-hydroxy-4-methoxy)benzylamine)
- 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
- 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
- 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
- 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
- 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
- 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
Audited Supplier
Audited Supplier
Audited Supplier
Audited Supplier
Audited Supplier